Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

HS-20117

Aliases
PM1080

2 clinical trials

3 indications

Indication
Solid Tumor
Indication
Non-Squamous Non-Small Cell Lung Cancer
Indication
NSCLC
Clinical trial
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HS-20117 in Participants With Advanced Solid Tumors
Status: Not yet recruiting, Estimated PCD: 2025-07-30
Clinical trial
A Phase Ib/III Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Immunogenicity of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer
Status: Not yet recruiting, Estimated PCD: 2026-06-01